The impact of the number of CD34+ cells infused on the hematologic recovery after autologous peripheral blood stem cell (PBSC) transplantation.

被引:0
|
作者
Palomera, L
Azaceta, G
Varo, MJ
Moreno, JA
Olave, T
Domingo, JM
Mayordomo, JI
Gutiérrez, M
机构
[1] Clin Hosp, Dept Hematol, Zaragoza, Spain
[2] Clin Hosp, Dept Oncol, Zaragoza, Spain
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
4310
引用
收藏
页码:304B / 304B
页数:1
相关论文
共 50 条
  • [41] NEED OF RECONSIDERATION OF MOBILIZATION STRATEGY IN AUTOLOGOUS STEM CELL TRANSPLANTATION FOR MULTIPLE MYELOMA: RESULTS OF THE POSITIVE IMPACT OF HIGH NUMBER OF CD34+ INFUSED CELLS
    Michallet, M.
    Sobh, M.
    Nicolini, N.
    Raus, N.
    Barraco, F.
    Cannas, G.
    Chelghoum, Y.
    Clapsisson, G.
    Thomas, X.
    Labussiere, H.
    Duscastelle-Lepretre, S.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 194 - 195
  • [42] CD34+ cell enrichment for autologous peripheral blood stem cell transplantation by use of the CliniMACS device
    Després, D
    Flohr, T
    Uppenkamp, M
    Baldus, M
    Hoffmann, M
    Huber, C
    Derigs, HG
    JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH, 2000, 9 (04): : 557 - 564
  • [43] In vitro migratory capacity of CD34+ cells is related to hematopoietic recovery after autologous stem cell transplantation
    Voermans, C
    Kooi, MLK
    Rodenhuis, S
    van der Lelie, H
    van der Schoot, GE
    Gerritsen, WR
    BLOOD, 2001, 97 (03) : 799 - 804
  • [44] CD34+ peripheral blood stem cells (PBSC) monitoring in patients with AML.
    Dassi, M
    Buscemi, F
    Pioltelli, P
    Perseghin, P
    Parma, M
    Pogliani, E
    Sciorelli, G
    BONE MARROW TRANSPLANTATION, 1998, 21 : S17 - S17
  • [45] L-selectin and integrin expression on CD34+ peripheral stem cells correlates with myeloid recovery after transplantation.
    Buccisano, F
    Venditti, A
    Tamburini, A
    Del Poeta, G
    Picardi, A
    Rainaldi, A
    Del Moro, B
    Epiceno, AM
    Masi, M
    Amadori, S
    BONE MARROW TRANSPLANTATION, 1998, 21 : S236 - S236
  • [46] Autologous transplant with peripheral blood immunoselected CD34+ cells in hematologic malignancies.
    DiMario, A
    Sica, S
    Salutari, P
    Micciulli, G
    Teofili, L
    LaBarbera, EO
    Etuk, B
    Menichella, G
    Leone, G
    EXPERIMENTAL HEMATOLOGY, 1996, 24 (09) : 119 - 119
  • [47] Autologous CD34+ selected peripheral stem cell transplantation (ASCT/CD34+) for multiple sclerosis (MS).
    Carreras, E
    Saiz, A
    Graus, F
    Marín, P
    Urbano-Ispizua, A
    Mercader, JM
    Martínez, C
    Rovira, M
    Mazzara, R
    Merino, A
    Tolosa, E
    Montserrat, E
    BONE MARROW TRANSPLANTATION, 1999, 23 : S33 - S33
  • [48] Hematologic recovery after autologous PBPC transplantation: importance of the number of postthaw CD34+cells
    Feugier, P
    Bensoussan, D
    Girard, F
    Alla, F
    Schuhmacher, A
    Latger-Cannard, V
    Hulin, C
    Witz, F
    Witz, B
    Carret, AS
    Bordigoni, P
    Lederlin, P
    Janot, C
    TRANSFUSION, 2003, 43 (07) : 878 - 884
  • [49] Impact of a Low CD34+ Cell Dose on Allogeneic Peripheral Blood Stem Cell Transplantation
    Yamamoto, Chihiro
    Ogawa, Hiroyasu
    Fukuda, Takahiro
    Igarashi, Aiko
    Okumura, Hirokazu
    Uchida, Naoyuki
    Hidaka, Michihiro
    Nakamae, Hirohisa
    Matsuoka, Ken-Ichi
    Eto, Tetsuya
    Ichinohe, Tatsuo
    Atsuta, Yoshiko
    Kanda, Yoshinobu
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (04) : 708 - 716
  • [50] The impact of the CD34+ cell dose on engraftment in allogeneic peripheral blood stem cell transplantation
    Ilhan, O
    Arslan, Ö
    Arat, M
    Beksaç, M
    Akan, H
    Özcan, M
    Gürman, G
    Konuk, N
    Uysal, A
    Koç, H
    TRANSFUSION SCIENCE, 1999, 20 (01): : 69 - 71